正常血管和肿瘤血管生成的调节机制研究进展

被引:19
作者
孙慧勤
邹仲敏
卞修武
陈意生
史景泉
机构
[1] 第三军医大学西南医院病理学研究所,第三军医大学西南医院病理学研究所,第三军医大学西南医院病理学研究所,第三军医大学西南医院病理学研究所
关键词
血管生成; 基底膜; 血管形成; 内皮细胞; 血小板反应蛋白; 抑制因子; 血小板源内皮细胞生长因子; 血管壁细胞; 血管期; 管腔样结构;
D O I
暂无
中图分类号
R730.2 [肿瘤病理学、病因学];
学科分类号
100214 ;
摘要
引用
收藏
页码:63 / 65
页数:3
相关论文
共 23 条
[1]  
l Selective ab lation ofimm ature b lood vessels in estab lished hum an tumors followsvascu lar endothelial growth factor w ithdrawal. Ben jam in LE,Golijan in D,Itin A,et a. J C lin In-vest . 1999
[2]  
Vascular endothelial growth factor,a multifunctional polypeptide. Stephan CC,Brock TA. Puerto Rico Health Sciences Journal . 1996
[3]  
Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy. Griffiths L,Stratford IJ. British Journal of Cancer . 1997
[4]  
Regulation of tumor growth and metastasis by thrombospondin-1. Roberts D D. The FASEB Journal . 1996
[5]  
Vascular endothelial growth factor (VEGF) mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. NOR JE. CHRISTENSEN J,MOONEY DJ,et al. American Journal of Pathology . 1999
[6]  
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Maisonpierre PC,Suri C,Jones PF,et al. Science . 1997
[7]  
Fighting cancer by attacking its blood supply. Folkman J. Scientific American . 1996
[8]  
Endostatin:an endogenousinh ib itor of angiogenesis and tumor growth. O′Reilly MS,Boehm T,Sh ing Y,et al. Cell . 1997
[9]  
Transforminggrowthfactor b. RobertsA,SpornM. molecularandcel lularbiologyofwoundrepair . 1996
[10]  
Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Millauer B,Longhi MP,Plate KH,et al. Cancer Research . 1996